Skip to Main Content

Paper Details

A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics.
Nat Commun
2
2023
-, CRISPR, PRKDC, cancer, cancers, cell line, cell lines, doxorubicin, drug, drug-treated cells, druggable gene, druggable genes, extracranial pediatric solid tumor, high-risk neuroblastoma cells, neuroblastoma, patient, patients, treated cells
Author NameAffiliation
Duane G CurrierSt. Jude Children's Research Hospital
Duane G CurrierSt. Jude Children's Research Hospital
Jun QiDana-Farber Cancer Institute
Jun QiHarvard Medical School
Shondra M Pruett-MillerCenter for Advanced Genome Engineering, St. Jude Children's Research Hospital
Shondra M Pruett-MillerSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
Taosheng ChenSt. Jude Children's Research Hospital
  • 1 - 9

Datasets

Release 1.2